Amygdalin promotes the activity of T cells to suppress the progression of HBV-related hepatocellular carcinoma via the JAK2/STAT3 signaling pathway

BACKGROUND: Hepatitis B virus (HBV) infection is a high-risk factor of hepatocellular carcinoma (HCC). Cellular immune responses are essential for HCC development, and the CD4+ and CD8+ T subtypes are identified as the primary anti-tumor immune cells. In the study, we investigated the effect and mec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ruoyu, Zhang, Dong, Sun, Kewei, Peng, Jianping, Zhu, Wenfang, Yin, Sihan, Tang, Dan, Wu, Yunan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802162/
https://www.ncbi.nlm.nih.gov/pubmed/33435880
http://dx.doi.org/10.1186/s12879-020-05713-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802162/
https://www.ncbi.nlm.nih.gov/pubmed/33435880
http://dx.doi.org/10.1186/s12879-020-05713-0

Ejemplares similares